Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31739| Title: | Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy. | Austin Authors: | Cao, Zhipeng;Burvenich, Ingrid J;Zhao, Kening;Senko, Clare ;Glab, Jason;Fogliaro, Renee;Liu, Zhanqi;Jose, Irvin;Puthalakath, Hamsa;Hoogenraad, Nick J;Osellame, Laura D;Scott, Andrew M | Affiliation: | Department of Biochemistry and Genetics, La Trobe University, Melbourne, VIC 3086, Australia. Olivia Newton-John Cancer Research Institute Department of Biochemistry and Genetics, La Trobe University, Melbourne, VIC 3086, Australia. Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia. Molecular Imaging and Therapy |
Issue Date: | 10-Nov-2022 | Date: | 2022 | Publication information: | Cancers 2022; 14(22) | Abstract: | Developing therapies for cancer cachexia has not been successful to date, in part due to the challenges of achieving robust quantitative measures as a readout of patient treatment. Hence, identifying biomarkers to assess the outcomes of treatments for cancer cachexia is of great interest and important for accelerating future clinical trials. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31739 | DOI: | 10.3390/cancers14225533 | ORCID: | 0000-0003-4142-6190 0000-0001-8384-2403 0000-0002-8039-8391 |
Journal: | Cancers | PubMed URL: | 36428623 | Type: | Journal Article | Subjects: | LCN2 RNA-seq biomarker cancer cachexia |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.